On November 21st, Opcons said that it was announced yesterday evening that it plans to cooperate with Hefei Sunshine Medical Technology Co., Ltd. (hereinafter referred to as Sunshine Medical ), Beijing Boao Jingdian Biotechnology Co., Ltd. (hereinafter referred to as Boao Jingdian), Anhui. Boao Gene Technology Co., Ltd. (hereinafter referred to as Boao Gene) jointly established Anhui Boao Medical Genetic Testing Co., Ltd. (tentatively, the pre-approval of the enterprise name by the industrial and commercial registration department shall prevail, hereinafter referred to as the joint venture company).
The announcement revealed that the parties had signed this cooperation agreement on November 19. The registered capital of the joint venture company is 30 million yuan, of which Optimus has invested 5.7 million yuan, accounting for 19% of the total registered capital; Sunshine Medical invested 15.3 million yuan, accounting for 51% of the total registered capital; Boao Jingdian invested 6 million yuan, Accounted for 20% of the total registered capital; Boao Gene contributed 3 million yuan, accounting for 10% of the total registered capital.
After the establishment of the joint venture company, it will carry out business activities around genetic testing services and related businesses, especially genetic testing technology for the diagnosis of birth defects, hereditary diseases and tumors, prenatal diagnosis, newborn screening, individualized treatment, chronic disease Exploration of medical diagnostics and other aspects of management.
OpconVision is an eye-vision technology company that focuses on R&D, production, sales and eye-vision services. The main business is non-surgical vision correction. It was publicly listed on the GEM of the Shenzhen Stock Exchange in January 2017. According to Tianyue data, there are currently 34 companies in Optronic's shareholding holdings, but the main business still focuses on the upstream and downstream of genetic testing. The last time about the company's project occurred on June 29, Optek decided to cancel the Shaanxi Optek based on the future regional development planning layout, resource integration and optimization configuration considerations.
Last month, Opcon released the Q3 financial report for 2018. During the reporting period, Opcon considered 156 million yuan, an increase of 52.13% over the same period of the previous year; the net profit attributable to shareholders of listed companies was 82.033 million yuan, an increase of 50.96% over the same period of the previous year. However, Opcoll, currently at the edge of the total market value of 9 billion yuan, wants to catch up with Aier Ophthalmology, which has a total market capitalization of more than 66 billion yuan. There is still a long way to go.
Oppo will use its own funds to invest in the establishment of a joint venture company. The purpose is to give full play to the resource advantages and technological advantages of all parties through joint ventures and cooperation, so as to help them form cross-industry complementarities and accelerate the strategic layout of various fields. The reason for choosing the field of medical genetic testing is to consider the possibility and historical opportunity of this technology for the big health industry.
In recent years, the new medical technology for genetic testing has been strongly supported by national policies. The “13th Five-Year Plan for Biotechnology Innovation†and the “Notice of the National Development and Reform Commission on Implementing Major Engineering Packages for Emerging Industries†and other related documents have all taken key projects. Deploy. On the other hand, the medical conditions in Anhui Province still need to be improved, and genetic technology has a lot of room for development in genetic disease detection, drug selection, and health management.
The joint venture intends to accurate medical basis to further explore the genetic research, applied research and development to accurate diagnosis of translational medicine. However, adult joint ventures are only the first step in genetic testing. Although the project's partners, Boao Jingdian, Boao Gene, and Sunshine Medical, can provide support for biological information, marketing networks and resource channels, how to improve the synergy effect of cooperation will be tested by time.
In addition, China's genetic testing market still needs to be further integrated. If the joint venture's products are positioned in the medical-grade market, how to enter the hospital and eliminate the public's misunderstanding of genetic testing, avoiding the similar public relations crisis of “Hua Da Cancerâ€, may become a problem that needs to be considered; if it is positioned at the consumer level The market, how to stand out in the "post-price war era" is also the top priority of future development.
Pain Relief Patch(Pain Areas)
Pain Relief Patch
[Name] Medical Cold Patch
[Package Dimension] 6cm×8cm 4pieces/box
The pain relief patch is composed of three layers, namely, backing lining, middle gel and protective film. It is free from pharmacological, immunological or metabolic ingredients.
[Scope of Application]
For cold physiotherapy, closed soft tissue only.
[Indications]
The patches give fast acting pain relief for strains, sprains, cramp, bruises, swollen areas or joint stiffness.
[How To Use a Patch]
Please follow the Schematic Diagram. One piece, one time.
The curing effect of each piece can last for 6-8 hours.
[Attention]
Do not apply the patch on the problematic skin, such as wounds, eczema, dermatitis,or in the eyes. People allergic to herbs and the pregnant are advised not to use the medication. If swelling or irritation occurs, please stop using and if any of these effects persist or worsen.notify your doctor or pharmacist promptly. Children using the patch must be supervised by adults.
[Storage Conditions]
Store below 30c in a dry place away from heat and direct sunlight.
Pain Relief Patch(Pain Areas),Shouler Pain Relief Patch,Joints Pain Relief Patch, Muscle Pain Relief Patch
Shandong XiJieYiTong International Trade Co.,Ltd. , https://www.xjplaster.com